RECRUITINGINTERVENTIONAL

The Effect of Walking and Grounding in Women With Breast Cancer

The Effect of Walking and Grounding on Pain Intensity, Fatigue Level, and Sleep Quality in Women With Breast Cancer

About This Trial

This randomized controlled trial was conducted to examine the effect of walking and grounding on pain intensity, fatigue level and sleep quality in women diagnosed with breast cancer.

Who May Be Eligible (Plain English)

Who May Qualify: - 18 years of age or older, - Can read and write and speak Turkish, - Diagnosed with primary breast cancer and know the diagnosis, - Volunteered to participate in the research, - Living in Ankara province, - Paclitaxel or Paclitaxel-Transtuzumab based chemotherapy treatment initiated, - Eastern Cooperative Oncology Group (ECOG) Scale 0 or 1, - NCI-CTCAE v5.0 Pain, fatigue and sleep toxicity grade 1 or 2, - You have a phone with an iOS or Android processor, Who Should NOT Join This Trial: - Open wounds or edema of the hands and feet, - NCI-CTCAE v5.0 motor and sensory peripheral neuropathy with toxicity grade 3,4 or 5, - People with a disability that would prevent them from walking, - Diagnosed cardiovascular and pulmonary disorders, - Diagnosed psychiatric illness, - Communication problems, - Bone metastases, - Bilateral mastectomies, Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language

Inclusion Criteria: * 18 years of age or older, * Can read and write and speak Turkish, * Diagnosed with primary breast cancer and know the diagnosis, * Volunteered to participate in the research, * Living in Ankara province, * Paclitaxel or Paclitaxel-Transtuzumab based chemotherapy treatment initiated, * Eastern Cooperative Oncology Group (ECOG) Scale 0 or 1, * NCI-CTCAE v5.0 Pain, fatigue and sleep toxicity grade 1 or 2, * You have a phone with an iOS or Android processor, Exclusion Criteria: * Open wounds or edema of the hands and feet, * NCI-CTCAE v5.0 motor and sensory peripheral neuropathy with toxicity grade 3,4 or 5, * People with a disability that would prevent them from walking, * Diagnosed cardiovascular and pulmonary disorders, * Diagnosed psychiatric illness, * Communication problems, * Bone metastases, * Bilateral mastectomies,

Treatments Being Tested

OTHER

Walking Group

Patients will be asked to walk for 30 minutes at least 3 times for 8 weeks. In order to ensure regular follow-up, patients will be asked to write on the walking tracking form when they walk and the number of steps before they start walking and the number of steps after walking using the application.

OTHER

Grounding Group

Patients will be asked to walk with a grounding stick for 30 minutes at least 3 times for 8 weeks. Patients will be asked to fill in the walking follow-up form and grounding follow-up form for regular follow-up.

Locations (1)

Gazi University Health Research and Application Center Gazi Hospital

Ankara, Turkey (Türkiye)